Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
British Journal of Pharmacology
|
April 1, 1989
ICI 204448: a kappa-opioid agonist with limited access to the CNS
J S Shaw, J A Carroll, P Alcock, et al.
The Journal of Applied Psychology
|
July 2, 1998
More than suggestion: the effect of interviewing techniques from the McMartin Preschool case
S Garven, J M Wood, R S Malpass, et al.
Neuropeptides
|
November 1, 1986
Specificity of the opioid affinity reagent, DALECK, in a set of isolated tissue assay systems
E Peers, J S Shaw, M J Rance, et al.
European Journal of Pharmacology
|
October 8, 1985
Conversion of dynorphin-(1-9) to [Leu5]enkephalin by the mouse vas deferens in vitro
L Miller, M J Rance, J S Shaw, et al.
The American Journal of Pathology
|
December 9, 2009
Infectious feline agranulocytosis
J S Lawrence, J T Syverton, J S Shaw, et al.
Pediatrics
|
April 1, 2000
Impact of an encounter-based prompting system on resident vaccine administration performance and immunization knowledge
J S Shaw, R C Samuels, E M Larusso, et al.
European Journal of Pharmacology
|
January 27, 1984
ICI 174864: a highly selective antagonist for the opioid delta-receptor
R Cotton, M G Giles, L Miller, et al.
Journal of Medicinal Chemistry
|
October 1, 1989
The xanthene-9-spiro-4'-piperidine nucleus as a probe for opiate activity
R H Galt, J Horbury, Z S Matusiak, et al.
Life Sciences
|
September 20, 1982
Selective antagonists at the opiate delta-receptor
J S Shaw, L Miller, M J Turnbull, et al.
Journal of Medicinal Chemistry
|
January 1, 1991
2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists
G F Costello, R James, J S Shaw, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
British Journal of Pharmacology
|
April 1, 1989
ICI 204448: a kappa-opioid agonist with limited access to the CNS
J S Shaw, J A Carroll, P Alcock, et al.
The Journal of Applied Psychology
|
July 2, 1998
More than suggestion: the effect of interviewing techniques from the McMartin Preschool case
S Garven, J M Wood, R S Malpass, et al.
Neuropeptides
|
November 1, 1986
Specificity of the opioid affinity reagent, DALECK, in a set of isolated tissue assay systems
E Peers, J S Shaw, M J Rance, et al.
European Journal of Pharmacology
|
October 8, 1985
Conversion of dynorphin-(1-9) to [Leu5]enkephalin by the mouse vas deferens in vitro
L Miller, M J Rance, J S Shaw, et al.
The American Journal of Pathology
|
December 9, 2009
Infectious feline agranulocytosis
J S Lawrence, J T Syverton, J S Shaw, et al.
Pediatrics
|
April 1, 2000
Impact of an encounter-based prompting system on resident vaccine administration performance and immunization knowledge
J S Shaw, R C Samuels, E M Larusso, et al.
European Journal of Pharmacology
|
January 27, 1984
ICI 174864: a highly selective antagonist for the opioid delta-receptor
R Cotton, M G Giles, L Miller, et al.
Journal of Medicinal Chemistry
|
October 1, 1989
The xanthene-9-spiro-4'-piperidine nucleus as a probe for opiate activity
R H Galt, J Horbury, Z S Matusiak, et al.
Life Sciences
|
September 20, 1982
Selective antagonists at the opiate delta-receptor
J S Shaw, L Miller, M J Turnbull, et al.
Journal of Medicinal Chemistry
|
January 1, 1991
2-(3,4-Dichlorophenyl)-N-methyl-N-[2-(1-pyrrolidinyl)-1-substituted- ethyl]-acetamides: the use of conformational analysis in the development of a novel series of potent opioid kappa agonists
G F Costello, R James, J S Shaw, et al.
Page
of 6